HARVARD BIOSCIENCE, INC. Foreign Currency Transaction Gain (Loss), Realized
HARVARD BIOSCIENCE, INC. (HBIO) reported Foreign Currency Transaction Gain (Loss), Realized of $16.00 thousand for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossRealized · last filed 2019-11-08
- HARVARD BIOSCIENCE, INC. foreign currency transaction gain (loss), realized for the quarter ending 2019-09-30 was $16.00K, a 77.78% increase year-over-year.
- HARVARD BIOSCIENCE, INC. foreign currency transaction gain (loss), realized for the quarter ending 2019-06-30 was -$10.00K.
- HARVARD BIOSCIENCE, INC. foreign currency transaction gain (loss), realized for the quarter ending 2019-03-31 was $10.00K, a 150.00% increase year-over-year.
- HARVARD BIOSCIENCE, INC. foreign currency transaction gain (loss), realized for the quarter ending 2018-12-31 was -$9.00K.
- HARVARD BIOSCIENCE, INC. foreign currency transaction gain (loss), realized for fiscal 2018 was -$15.00K.
| Period end | Foreign Currency Transaction Gain (Loss), Realized 3 month | Foreign Currency Transaction Gain (Loss), Realized 6 month | Foreign Currency Transaction Gain (Loss), Realized 9 month | Foreign Currency Transaction Gain (Loss), Realized 12 month |
|---|---|---|---|---|
| 2019-09-30 | $16.00K 10-Q · filed 2019-11-08 | $6.00K derived: sum of 2 quarters · filed 2019-11-08 | $16.00K 10-Q · filed 2019-11-08 | $7.00K derived: sum of 4 quarters · filed 2019-11-08 |
| 2019-06-30 | -$10.00K 10-Q · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | -$9.00K derived: sum of 3 quarters · filed 2019-08-08 | $0.00 derived: sum of 4 quarters · filed 2019-11-08 |
| 2019-03-31 | $10.00K 10-Q · filed 2019-05-08 | $1.00K derived: sum of 2 quarters · filed 2019-05-08 | $10.00K derived: sum of 3 quarters · filed 2019-11-08 | -$9.00K derived: sum of 4 quarters · filed 2019-11-08 |
| 2018-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $0.00 derived: sum of 2 quarters · filed 2019-11-08 | -$19.00K derived: sum of 3 quarters · filed 2019-11-08 | -$15.00K 10-K · filed 2019-03-18 |
| 2018-09-30 | $9.00K 10-Q · filed 2019-11-08 | -$10.00K derived: sum of 2 quarters · filed 2019-11-08 | -$6.00K 10-Q · filed 2019-11-08 | |
| 2018-06-30 | -$19.00K 10-Q · filed 2019-08-08 | -$15.00K 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $4.00K 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |